The effect of fordyse happiness model on depression, stress, anxiety and fatigue of multiple sclerosis patients

The effect of fordyse happiness model on depression, anxiety and fatigue of multiple sclerosis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014112420064N1

Enrollment

140

Registered

2015-04-02

Start date

2013-05-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Demyelinating diseases of the central nervous system

Interventions

Intervention 1: after obtaining the consent from from trial group, fordyce happiness program carried out in 8 sessions of 90 minutes once a week and happy principle taught with 14 element. Specified

Behavior

after obtaining the consent from from trial group, fordyce happiness program carried out in 8 sessions of 90 minutes once a week and happy principle taught with 14 element. Specified goals and tasks

In the control group during the routine activities are follow-up and after the collection of questionnaires in in both groups, fordyce happiness program was taught in two sessions in the control gro

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Main inclusion criteria include enabling read and write; having age range between 18 - 60 and complete the informed consent and main exclusion criteria include having history of other diseases such as mental disorders include major depression (according to records of the patient; and the treating physician) or bipolar disorder; addiction; other neurological disorders; and history of steroid use or relapse during the past 6 weeks.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Stress. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: DASS21 Standard Questionnaire.;Anxiety. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: DASS21 Standard Questionnaire.;Fatigue. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: Piper Standard Questionnaires.;Depression. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: DASS21 Standard Questionnaire.	—

Measure

Time frame

Stress. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: DASS21 Standard Questionnaire.;Anxiety. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: DASS21 Standard Questionnaire.;Fatigue. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: Piper Standard Questionnaires.;Depression. Timepoint: Baseline; Imediately After; 2 months After. Method of measurement: DASS21 Standard Questionnaire.

—

Secondary

Measure	Time frame
Quality of life. Timepoint: 6months After intervention. Method of measurement: SF-36 Standard Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFreidoon Khayeri

Tehran University of Medical Sciences

fkhayri@tums.ac.irkhayeri; f@iums.ackhayeri@health.gov.ir+98 21665815601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026